The Net Margin of Mayinglong Pharmaceutical Group Co Ltd (600993.SS) is 14.13%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2023-12-31 | 14.13% |
2022-12-31 | 13.56% |
2021-12-31 | 13.72% |
2020-12-31 | 15.01% |
2019-12-31 | 13.31% |
2018-12-31 | 8.02% |
2017-12-31 | 18.29% |
2016-12-31 | 11.90% |
2015-12-31 | 12.52% |
2014-12-31 | 12.43% |